Johnson & Johnson said on Thursday it was eliminating 900 positions from its Ortho-McNeil-Janssen Pharmaceutical unit in the latest downsizing move in the drug industry.
The reductions occurred across Ortho-McNeil-Janssen, but the majority of the jobs impacted were from sales, spokeswoman Kara Russell said.
Russell said attrition and hiring freezes were involved in the overall reduction, but she declined to say just how many people were losing their jobs.
"Some employees were informed earlier this week that their positions were being eliminated," Russell said.
More
No comments:
Post a Comment